NorthWest Biotherapeutics Inc (NWBO)

[The Danish Dude]

NWBO CHOSE ... as in, VOLUNTERED for releasing TLD TOGETHER with a publication.

That was a strategic as well as a tactical choice, obviously incited by a need to be able to support - beyond ALL doubt - the short TLD message, with scientific documentation.

We are constantly being p..... in the ears about "why does it take .... to TLD?" and "give me examples of other companies ...".

This is NOT other companies. This is Easy ... sorry NWBO.

And NWBO has a history of a 14 year long trial filled to the brim with "players" wanting to take down NWBO with all means, since DVVax-L would disrupt the cancer business and make a lot of big pharma players saying "goodbye" to billions and billions of dollars in lost revenue. Hitpieces in articles and on SoMe and ambulance chasing second rate lawfirms trying to earn an unhonest buck, by instigating fake lawsuits.

That was the days, leading to voluntarily stepping down to OTC in order to bring the DCVax-L trial to the finishing line.

NOT releasing TLD at the point they were able to, that is BEFORE march 2021, LP took away from the parties in questions - fudders and shorters alike - the narrative of questioning TLD, which they would've done if able to.

The publication could thus be started upon LATEST at that point in time, where statisticians had summaries, but was probably started upon before. So from that time to TLD eventually comes, is the time, that one should compare with the median time for getting clinical trial PIII data in a publication.

Thank you kindly for all the informative postings regarding NWBO having not done, what most other companies do with regards to TLD.

Looking at all the failed PIII trials in the glioblastoma arena, one could ask then, if perhaps if was time, that someone started approaching the finishing line in an unorthodox way, not only with regards to all the above justifying that strategy, but looking at all the catalysts accumulated after data lock, that points unequivocally on a trial success for DCVax.L.

Ignore the fud.